157 related articles for article (PubMed ID: 33582903)
1. Infection-associated Hemophagocytic Syndrome in Critically Ill Patients with COVID-19.
Yang K; Xing MY; Jiang LY; Cai YP; Yang LL; Xie NN; Chen J; Wang WX; Wang L; Zhu JL; Zhang DY; Ruan QR; Song JX
Curr Med Sci; 2021 Feb; 41(1):39-45. PubMed ID: 33582903
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
[TBL] [Abstract][Full Text] [Related]
4. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
Lorenz G; Moog P; Bachmann Q; La Rosée P; Schneider H; Schlegl M; Spinner C; Heemann U; Schmid RM; Algül H; Lahmer T; Huber W; Schmaderer C
Sci Rep; 2020 Oct; 10(1):18277. PubMed ID: 33106497
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Secondary Hemophagocytic Lymphohistiocytosis in Critically-Ill COVID-19 Patients.
Allen J; McCambridge MM; Kincaid H; Kalter JA
Cureus; 2021 Jul; 13(7):e16735. PubMed ID: 34513365
[TBL] [Abstract][Full Text] [Related]
6. Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis.
Dimopoulos G; de Mast Q; Markou N; Theodorakopoulou M; Komnos A; Mouktaroudi M; Netea MG; Spyridopoulos T; Verheggen RJ; Hoogerwerf J; Lachana A; van de Veerdonk FL; Giamarellos-Bourboulis EJ
Cell Host Microbe; 2020 Jul; 28(1):117-123.e1. PubMed ID: 32411313
[TBL] [Abstract][Full Text] [Related]
7. [Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?].
Alfaro-Murillo A; Lazo-Paéz G
Rev Chilena Infectol; 2021 Apr; 38(2):271-278. PubMed ID: 34184718
[TBL] [Abstract][Full Text] [Related]
8. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
Meazza Prina M; Martini F; Bracchi F; Di Mauro D; Fargnoli A; Motta M; Giussani C; Gobbin G; Taverna M; D'Alessio A
BMC Infect Dis; 2021 Aug; 21(1):811. PubMed ID: 34388982
[TBL] [Abstract][Full Text] [Related]
9. An elevated HScore is associated with poor clinical outcomes in COVID-19.
Benavente R; Peña C; Cid A; Cabello N; Bustamante P; Álvarez M; Henríquez E; Soto A; Rubilar E
Rev Med Chil; 2023 Feb; 151(1):15-22. PubMed ID: 37906742
[TBL] [Abstract][Full Text] [Related]
10. Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach.
Schnaubelt S; Tihanyi D; Strassl R; Schmidt R; Anders S; Laggner AN; Agis H; Domanovits H
Medicine (Baltimore); 2021 Mar; 100(12):e25170. PubMed ID: 33761694
[TBL] [Abstract][Full Text] [Related]
11. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
Yongzhi X
Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
[TBL] [Abstract][Full Text] [Related]
12. The Use of Ferritin to Identify Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis.
Grangé S; Buchonnet G; Besnier E; Artaud-Macari E; Beduneau G; Carpentier D; Dehay J; Girault C; Marchalot A; Guerrot D; Tamion F
Crit Care Med; 2016 Nov; 44(11):e1045-e1053. PubMed ID: 27441901
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.
Prilutskiy A; Kritselis M; Shevtsov A; Yambayev I; Vadlamudi C; Zhao Q; Kataria Y; Sarosiek SR; Lerner A; Sloan JM; Quillen K; Burks EJ
Am J Clin Pathol; 2020 Sep; 154(4):466-474. PubMed ID: 32681166
[TBL] [Abstract][Full Text] [Related]
14. Severe COVID-19-associated hyperinflammatory syndrome versus classic hemophagocytic lymphohistiocytosis: similarities, differences, and the way forward.
Yadav G; Malhotra H; Mehta P; Sachu R; Rizvi I; Bharti VR; Kumar M; Kumar N; Ali W; Verma SP; Puri B; Dandu H
J Investig Med; 2023 Mar; 71(3):244-253. PubMed ID: 36803041
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of 47 secondary hemophagocytic lymphohistiocytosis patients complicated with capillary leak syndrome.
Man C; Wang M; Yin G; Huang J; Cheng W; Wu X; Liu L; Gao X; Wang J; Tian T; Duan L; Xu J; Qiu H
Int J Hematol; 2021 Feb; 113(2):263-270. PubMed ID: 33037588
[TBL] [Abstract][Full Text] [Related]
16. Hemophagocytic lymphohistiocytosis diagnosed by bone marrow trephine biopsy in living post-COVID-19 patients: case report and mini-review.
Ioannou M; Zacharouli K; Doukas SG; Diamantidis MD; Tsangari V; Karakousis K; Koukoulis GK; Vageli DP
J Mol Histol; 2022 Aug; 53(4):753-762. PubMed ID: 35699822
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Performance of Hemophagocytic Lymphohistiocytosis Criteria and HScore in Critically Ill Patients With Severe Hemophagocytic Syndrome.
Valade S; Monseau G; Mariotte E; Darmon M
Crit Care Med; 2021 Sep; 49(9):e874-e879. PubMed ID: 33852445
[TBL] [Abstract][Full Text] [Related]
18. Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: Balancing immunosuppression.
Lubnow M; Schmidt B; Fleck M; Salzberger B; Müller T; Peschel G; Schneckenpointner R; Lange T; Hitzenbichler F; Kieninger M; Lunz D; Graf B; Brochhausen C; Weber F; Lüke F; Peterhoff D; Schuster P; Hiergeist A; Offner R; Hehr U; Wallner S; Hanses F; Schmid S; Weigand K; Geismann F; Poeck H; Pukrop T; Evert M; Gessner A; Burkhardt R; Herr W; Maier LS; Heudobler D
Int J Infect Dis; 2021 Feb; 103():624-627. PubMed ID: 33412272
[TBL] [Abstract][Full Text] [Related]
19. Hemophagocytic lymphohistiocytosis-how common and how severe is it as a complication of malaria? Retrospective case series and review of the literature.
Orth HM; Wiemer D; Schneitler S; Schönfeld A; Holtfreter MC; Gliga S; Fuchs A; Pfäfflin F; Denkinger CM; Kalbitz S; Fritzsche C; Hübner MP; Trauth J; Jensen BO; Luedde T; Feldt T
Infection; 2024 Apr; 52(2):471-482. PubMed ID: 37875775
[TBL] [Abstract][Full Text] [Related]
20. Clinical Value of
Liang J; Cao H; Wu B; Liu Y; He Y; Xu B; Sun Y; Ye B; Lin J
Front Immunol; 2021; 12():745211. PubMed ID: 34867971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
